Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...
In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s most ...
We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...
Hosted on MSN7mon
Does 10x Genomics (TXG) Have the Potential to Rally 85.65% as Wall Street Analysts Expect?10x Genomics (TXG) closed the last trading session at $20, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
In trading on Monday, shares of 10x Genomics Inc (Symbol: TXG) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $11.8955 per share. By comparison ...
10x Genomics (TXG) reported $183.98 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 17.8%. EPS of -$0.41 for the same period compares to -$0.15 a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback